glp-1 colorectal cancer mortality study november 2025 receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. In an analysis of more than 6,800 colon patients across Wegovy and Ozempic tied to
Description
This is all well and good for people with obesity (PwO) who also have diabetes, but what if Mr T had obesity without diabetes
None of the compounds discussed here should be used without medical supervision, a thorough health history review, and appropriate lab testing including growth hormone levels and IGF-1
How does Tirzepatide work
Retatrutide: the triple agonist Retatrutide activates GLP-1, GIP, and glucagon receptors
95% CI: 0.89-1.17)
If you are on either of those for diabetes, you keep getting them through your regular Part D plan
